Advisor Group’s Neurocrine Biosciences NBIX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2019
Q4 | $233K | Sell |
2,171
-306
| -12% | -$32.8K | ﹤0.01% | 2271 |
|
|
2019
Q3 | $224K | Sell |
2,477
-560
| -18% | -$50.6K | ﹤0.01% | 2230 |
|
|
2019
Q2 | $255K | Buy |
3,037
+459
| +18% | +$38.5K | ﹤0.01% | 2119 |
|
|
2019
Q1 | $227K | Sell |
2,578
-42
| -2% | -$3.7K | ﹤0.01% | 2180 |
|
|
2018
Q4 | $187K | Sell |
2,620
-11,722
| -82% | -$837K | ﹤0.01% | 2138 |
|
|
2018
Q3 | $1.76M | Buy |
14,342
+13,063
| +1,021% | +$1.61M | 0.02% | 700 |
|
|
2018
Q2 | $125K | Sell |
1,279
-235
| -16% | -$23K | ﹤0.01% | 2347 |
|
|
2018
Q1 | $125K | Buy |
1,514
+1,404
| +1,276% | +$116K | ﹤0.01% | 2370 |
|
|
2017
Q4 | $9K | Sell |
110
-1,404
| -93% | -$115K | ﹤0.01% | 4142 |
|
|
2017
Q3 | $92K | Buy |
1,514
+1,109
| +274% | +$67.4K | ﹤0.01% | 2478 |
|
|
2017
Q2 | $18K | Sell |
405
-821
| -67% | -$36.5K | ﹤0.01% | 3561 |
|
|
2017
Q1 | $53K | Buy |
1,226
+1,200
| +4,615% | +$51.9K | ﹤0.01% | 2656 |
|
|
2016
Q4 | $1K | Sell |
26
-161
| -86% | -$6.19K | ﹤0.01% | 4364 |
|
|
2016
Q3 | $9K | Buy |
187
+57
| +44% | +$2.74K | ﹤0.01% | 3621 |
|
|
2016
Q2 | $4K | Buy |
+130
| New | +$4K | ﹤0.01% | 3872 |
|